Abstract：
A typographical error appeared in the title of the article \"Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophora Decoction\", published in Current Pharmaceutical Design, 2022; 28(42): 3456-3468 [1]. Details of the error and a correction are provided below. Original: Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophora Decoction Corrected: Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophorae Decoction We regret the error and apologize to readers. The original article can be found online at: https://www.eurekaselect.com/article/127740.
摘要：
文章标题“HSP90抑制剂通过抑制MAPK途径治疗DSS诱导小鼠结肠炎的机制和复方苦参汤的协同作用”出现了印刷错误，发表在《当前制药设计》上，2022年；28（42）：3456–3468[1]。下面提供错误和校正的细节。原文：HSP90抑制剂通过抑制MAPK通路治疗DSS诱导小鼠结肠炎的机制及复方苦参汤的协同作用纠正：HSP90抑制剂通过抑制MAPK通路治疗DSS诱导小鼠结肠炎的机制及复方苦参汤的协同作用我们对错误表示遗憾，并向读者道歉。原始文章可以在网上找到：https://www。eurekaselect.com/article/127740.
